Australasian Diabetes Congress 2025

ADS Plenary Speaker

Dr Linnemann is a scientist with an extensive background in molecular biology, high throughput genomic analysis, and imaging. Her laboratory is in the Herman B Wells Center for Pediatric Research at Indiana University School of Medicine in Indianapolis, and she is a member of the Indiana Center for Diabetes and Metabolic Diseases. Research in the Linnemann lab is focused on diabetes; specifically, the study of the insulin-producing pancreatic beta-cells under conditions of inflammatory stress. We are particularly interested in how higher-level metabolic signals contribute to molecular crosstalk within the pancreatic islet and influence beta-cell adaptation to stress, specifically through studies focused on autophagy and the antioxidant response.
In addition to numerous awards throughout her career Dr. Linnemann is currently funded by a prestigious K01 Career Development Award from the National Institutes of Health (NIH). The primary focus of the Linnemann laboratory is to understand mechanisms of pancreatic β-cell death/survival, islet compensatory adaptation to cellular stress, and how these factors contribute to diabetes pathogenesis.